NEW YORK (360Dx) – Myriad Genetics said this week a top-five insurer has issued a positive medical policy decision for the Prolaris prostate cancer test. Myriad, through a spokesman, declined to identify the insurer. The firm noted that the positive coverage decision follows updated guidelines from the National Comprehensive Cancer Network for prostate cancer supporting Prolaris as a standard of care genetic test for men diagnosed with low and favorable-intermediate risk prostate cancer.
The College of American Pathologists has accredited Baby Genes, a provider of next-generation sequencing-based clinical diagnostics for newborn screening, newborn diagnostics, and family planning. CAP inspectors evaluate a clinical lab's record and quality control procedures as part of the accreditation process. They also assess the lab's equipment, facilities, safety programs, staff qualifications, policies and procedures, and overall management.
Several organizations said this week they are collaborating to develop clinical practice guidelines for diagnosing and managing von Willebrand disease. The organizations are the American Society of Hematology, International Society on Thrombosis and Haemostasis, World Federation of Hemophilia, and University of Kansas Medical Center. Two expert panels will create recommendations for diagnosis and management. The panels will comprise more than 20 individuals, including hematologists in the US and elsewhere, VWD patients, and scientists with expertise in evidence synthesis and appraisal and guideline development methodology.
ASH President Alexis Thompson said that VWD presents a challenge for clinicians and many patients remain undiagnosed until they have a severe bleeding episode. "These guidelines will provide clinicians and patients with clear recommendations for the timely diagnosis of VWD and appropriate management of symptoms," Thompson said in a statement.
In Brief This Week is a selection of news items that may be of interest to our readers but had not previously appeared on GenomeWeb.